Save Product
Product Details
Source
Anti-Rabies virus glycoprotein G Antibody, Mouse IgG1 (523-11) is a mouse monoclonal antibody recombinantly expressed in HEK293 cells.
Antibody Type
Recombinant Monoclonal
Clone
523-11
Isotype
Mouse IgG1, Kappa
Host Species
Mouse
Reactivity
Virus
Immunogen
Rabies virus glycoprotein G
Specificity
This antibody specifically binds to the glycoprotein of Rabies virus.
Purification
Protein A purified / Protein G purified.
Aggregation
Less than 5%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA
Immobilized Rabies virus Glycoprotein, His Tag (Cat. No. RAG-V55H5) at 1 μg/mL (100 μL/well) can bind Mouse Glycoprotein G Antibody, Mouse IgG1 (523-11) (Cat. No. RAG-M305) with a linear range of 0.1-2 ng/mL (QC tested).
Protocol
Customer Reviews Writing Reviews
1***52022-08-10
LikesWhen we first purchased ACRO's rabies G protein, our aim was to use it as a replacement for imported test kits. We have been trying to use it for testing post-exemption sera from animals, but it has always been paired with other brands of rabies antibodies for the development of analytical methods and evaluation of immunization effectiveness. Now shown by the data report, this RAG-M305 from ACRO has much better results compared with the previous antibodies used in our laboratory.
Background
Recent Advances
Contact Us
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
Drug Candidate Licensing
